Conferences
Upcoming MDPI Conferences (0)
No conferences found for the selection.Upcoming Partner Conferences (2)
London, UK
Now heading into our 8th year, CHI's Immuno-Oncology Summit Europe is the premier event for immuno-oncology professionals who want to learn about the latest advancements and innovations in the field. The Summit will take place on 23–25 April 2024 in London, one of the world's leading hubs for biomedical research and clinical development.
With a comprehensive agenda encompassing four distinct yet related programs—Modulating the Tumour Microenvironment, Next-Generation Cell-Based Immunotherapies, Bispecific and Multi-specific Antibody Therapeutics, and Therapeutic Cancer Vaccines—the Summit promises to be an invaluable forum for the exchange of cutting-edge research and a platform for collaboration among the global immuno-oncology community.
Highlights of the Summit include a plenary keynote session featuring two distinguished speakers; engaging breakout discussions that bring peers together to deliberate the most pressing or contentious topics in the field; a balanced faculty of speakers from industry and academia; posters showcasing innovative studies; and an Exhibit Hall where technological leaders in the IO space gather.
Join us at the Immuno-Oncology Summit Europe 2024 to meet peers, exchange ideas, and find collaborators to accelerate your next IO program. Learn more and register today at Immuno-OncologyEurope.com.
Montpellier, France
The 12th Antibody Industrial Symposium AIS2024, jointly organized by the scientific society LabEx MAbImprove and MabDesign, the French association of the Biotherapy Industrial sector, will be held on June 20–21 2024, in Montpellier, France. The AIS2024 is the ideal conference for scientists, industrials, clinicians, and policy makers to discuss therapeutic antibodies and more! This year’s 2-day-programme is organized into several segments covering the hot topics in research on antibodies, recombinant proteins, CART cells and other biopharmaceuticals and development. Moreover, the program will allow opportunities for one-to-one meetings and companies to virtually showcase their new products and technologies with dedicated time for business partnering.
Call for Abstracts: Submit your Abstract to give a Pitch presentation or present your Poster at the AIS2024. The abstract submission deadline is April 12th, 2024! Check the guidelines at https://aiscongress.com/abstracts.php.
Key words: mAbs; bi- and multi-specifics; immunotherapy; developability; Ab-like molecules; immunocytokines; adoptive cell therapy; CAR-T cells; drug discovery; ADCs; analytics; patient stratification; PK/PD; AI and machine learning; bioprocessing
